HEIDELBERG PHARMA AG NPV revenue breakdown overview

HEIDELBERG PHARMA AG NPV revenue for the last year amounted to 11.98 M EUR, the most of which — 6.85 M EUR — came from its highest performing source at the moment, Antibody Drug Conjugates, the year earlier bringing 9.86 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought HEIDELBERG PHARMA AG NPV 4.67 M EUR, and the year before that — 4.74 M EUR.